![](https://investorshub.advfn.com/uicon/674631.png?cb=1603990488)
Sunday, December 01, 2019 1:24:22 PM
I don't use Coca Cola as an analogy for IPE because they have COMPLETELY different supply and demand structures. It is understandable how diffuse the analogy became because AMRN used Coke vs Pom to argue their ITC case. And the analogy also works to an extent in that patients should have it within reach like a Coke and AMRN is attempting a hybrid position in terms of DTC pharma marketing.
But, Coke is regulated like a CPG not a drug. In consumer research on beverages, there is NO product testing level at which Americans say "no, that's too sweet." Even if you discount that research somewhat because consumer panels want to please the researchers (CPG world is broken after all - look at Nielsen split this month as Connect isn't as profitable as it once was), it still shows that soda makers know they can keep adding more sugar, concentrating it further with a new flavor and slapping a new label on it to chase "premiumization", and we like it more. It's a very short time table from R&D to new label in CPG land compared to pharma.
In the US according to the USDA we consume per capita annually
40 lbs of sugar
22 lbs of hfcs
10 lbs of other sweeteners (excluding alcohol sugars).
Practically all regions on the planet grow sugar cane, sugar beets and/or corn.
Global supply in a given year of those 3 sweetener sources alone is about:
290,000,000 million mt
190,000,000 annual production (and the rest is carryover stock or in some phase of production)
The price of sugar trades between $0.14-$.0.25/lb because of all the subsidies, IMF loans, and its cash crop status for developing countries. It is easy to sell more sweetener - people crave it and the source is everywhere and cheap.
So, like soy and seed oils (close to 600,000,000 million mt annual production) the world consumes a lot of these easily mass produced sweet & addictive energy sources.
Contrast that with fishoil supply- 1,000,000 mt which in recent el nino years has been down as low as 835,000 mt. From that, O-3 DHC demand fluctuates with current (revised) numbers "showing" 185,000...210,000 mt (from 165,000-185,000 mt in the last decade).
There's a bit of a structural difference between these analogies.
See below for more trade data:
![](http://investorshub.advfn.com/uimage/uploads/2019/12/1/lsptvglobal_sugar_stocks.jpg)
![](http://investorshub.advfn.com/uimage/uploads/2019/12/1/zxnlfglobal_sugar_price_2019.jpg)
![](http://investorshub.advfn.com/uimage/uploads/2019/12/1/hglnjus_sugar_deliveries.jpg)
Recent AMRN News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM